SARS-CoV-2/COVID's major underlying cause: Mitochondrial dysfunction, loss of membrane potential (ΔΨ m) and impaired OXPHOS under hypoxic conditions
In
this part of the "Deterioration in SARS-CoV-2 series", I will discuss
the key role of mitochondria in the energy production process and ROS
generation. As is known since SARS-CoV-1 (2003), the proteins of the
coronavirus are able to "hack" mitochondria and get access to host cells
via the "hijacking of mitochondria". I will offer insight into the
properties of the virus that impair mitochondrial health which by doing
so, contribute to viral replication and suppression of the immune
response. I will also discuss possible treatment options to effectuate
"mitochondrial redox".
1. Mitochondrial function
1.1 Substrate feeding through the TCA and OXPHOS
1.2 What impaired mitochondrial function amounts to
1.3 The Warburg effect
2. COVID-mitochondriopathy and hypoxia
2.1 Hypoxic conditions in COVID
2.2 The Warburg Effect in COVID via PI3K/AKT/mTOR and MAPK/ERK pathways induce microthrombosis
2.3 Inhibition of Bcl-2 family members leads to necrotic cell death
2.4 NSP4 and ORF9b of SARS-CoV-2 damage mitochondrial membrane potential (ΔΨ
m) and induce release of mtDNA into the cytosol
2.5 Fibrosis and mitochondrial dysfunction
2.5.1 Alleviating pulmonary fibrosis through restoration of mitochondrial integrity and REDOX (Metformin)
2.5.2 Mitophagy impairment in spite of enhanced PINK1/Parkin
2.6 Mitochondrial damage leading to mismatched ventilation/perfusion (V/Q) in COVID
3. Mitchondrial DNA and TLR-9 contribute to SARS-endothelial damage
1. Mitochondrial function
Mitochondria
are located on and in most cells, except for mature erythrocytes
(COVID-19 sepsis: revisiting mitochondrial dysfunction in pathogenesis,
aging, inflammation and mortality, Inflammation Research, 7 August
2020). A 2015 study revealed that mitochondria located on the edge of
muscle cells are optimized to generate membrane voltage (power supply),
while interconnected mitochondria inside muscle cells are optimized to
use voltage in order to produce ATP (High-resolution 3D images reveal the muscle mitochondrial power grid, NIH News, 30 July 2015).
Mitochondria
contribute to cellular homeostasis through generation of ATP and low
levels of ROS, required for cell signaling. Endothelial cells are
supplied with ATP by glycolysis, whilst ROS generation towards
endothelial cells depends on mitochondria.
1.1 Substrate feeding through the TCA and OXPHOS
Glucose
(metabolized via glycolysis and pyruvate oxidation), fatty acids
(metabolized via fatty acid-beta-oxidation) and amino acids (via
oxidative deamination) feed into the TCA cycle (or Krebs cycle) before
entering the Electron Transport Chain (ETC) within the mitochondrial
matrix, in order to undergo Oxidative Phosphorylation (OXPHOS).
Under
normoxic conditions, cells metabolize glucose into pyruvate in order to
feed the TCA. The TCA cycle produces Nicotinamide adenine dinucleotide
(NADH) to substrate OXPHOS in order to generate ATP. Beta-oxidation of
fatty acids or pyruvate form substances to produce Acetyl-CoA within the
mitochondrial matrix. Citrate synthase converts acetyl-CoA to citrate.
Succinyl-CoA is hydrolized (Mitochondrial ETC: OXPHOS, oxidant production and methods of measurement, Redox Biology 37 (2020)).
Five
protein complexes are located inside the inner mitochondrial membrane,
close to the TCA cycle. Complexes I-IV make up the Electron Transport
Chain; Complex V is part of the ATP Synthase. The TCA cycle provides
NADH and FADH2 to the ETC. NADH and FADH2 donate a pair of electrons to
Complex I and II of the Electron Transport Chain. Through a coupling
synthase, Complex V is tied to the generation of ATP from ADP
(Mitochondrial electron transport chain: Oxidative phosphorylation,
oxidant production and methods of measurement, Redox Biology 37 (2020); Feeding Mitochondria: Potential Role of nutritional components to improve critical illness convalescence, Clinical Nutrition 38 (2019)).
1.2 What impaired mitochondrial function amounts to
Mitochondrial
function is essential for neurological functions. Age-related
neurodegeneration is a consequence of age-affected mitochondrial
degeneration. Pathogens, such as viruses, impair mitochondrial health as
well. During the ATP synthase through oxidative phosphorylation
(OXPHOS), oxidative stress is generated. Excess Reactive Oxygen Species
(ROS) is harmful to mitochondria. ROS damages lipids, proteins and
nucleic acids, leading to impaired metabolism, cell death, impaired
glucose metabolism, impaired calcium homeostasis and DNA damage. Damage
Associated Patterns (DAMP) generate ROS in response to the detection of
viral DNA. Oxidized mitochondrial DNA, cardiolipin and cytochrome from
damaged mitochondria are released into the cytoplasm,leading to enduring
systemic inflammation (COVID: a Mitochondrial Perspective, DNA and Cell Biology Vol. 40 Number 6, 2021).
Hyperferritinemia,
accumulation of iron occurring due to COVID, induces ROS formation.
Iron homeostasis dysregulation incites platelet destruction. The
cytokine cascade contributes to ROS formation through TNF-α, IFN-, IL-6
and IL-10, stimulating the pro-inflammatory profile. IL-6 and TNF-α
impair the processes of ATP and OXPHOS. This amounts to the loss of
mitochondrial membrane potential, increasing mitochondrial permeability
("leaky mitochondria").
Upon losing integrity, mitochondrial DNA
is released into the intracellular fluid, inducing an inflammatory
profile of IL1-β and IL-6 through stimulation of the inflammasome NLRP3.
Damage to mitochondria in epithelial alveolar cells contributes to the
release of inflammatory CXCL-8, CCL3, CCL4, CCL20, IL-6 and IL-12.
Hyperferritinemia drives mitochondrial respiration from aerobic to an
anaerobic state.
In SARS-CoV-2 infection, TCA cycle/Krebs
cycle metabolites citrate, malate, fumarate and aconitate are shown to
be decreased through depression of TCA cycle genes. TCA cycle and OXPHOS
are depressed in COVID, indicating altered cellular metabolism.
Furthermore, choline uptake is increased by polarized macrophages during
SARS-CoV-2 infection, subsequently leading to choline downregulation.
On the other hand, homocysteine upregulation in COVID contributes to
endothelial damage (Metabolic reprogramming and epigenetic changes of
vital organs in SARS-CoV-2-induced systemic toxicity, JCI Insight 2021;
6(2)).
1.3 The Warburg effect
The Warburg Effect marks
a shift from the TCA cycle and oxidative phosphorylation to aerobic
glycolysis by glucose uptake and increased fermentation of glucose to
lactose, even in the presence of abundant oxygen (Neoplasia, Robbins
& Cotran Pathologic Basis of Disease, 2021). Aerobic glycolysis is
exploited by rapidly replicating cells and necessary for cell
proliferation, viral replication and drug resistance. Initially, aerobic
glycolysis is necessary for proliferation of neutrophils and M1
macrophage activation. As a first line of defense, neutrophils and M1
macrophages depend on glycolysis and Fatty Acid Synthesis (FAS).
2. COVID-mitochondriopathy and hypoxia
2.1 Hypoxic conditions in COVID
Under
hypoxic conditions, pyruvate is converted to lactate. Hypoxia-inducible
factor-1 (HIF-1), consisting of HIF-1a and HIF-1-beta, shifts
metabolism from mitochondrial respiration towards aerobic glycolysis.
COVID/SARS-CoV-2-infection is marked by increased levels of pyruvate,
pyruvate kinase and lactate dehydrogenase (LDH), indicating glycolysis
with lactate fermentation.
Hypoxia occurs when leukocytes are
activated in response to Interferon activation, as well as in response
to Pathogen-Associated Patterns (PAMP) and Damage-Associated Patterns
(DAMP). DAMP activate the inflammatory NF-kB-pathway and STING
(Interferon Genes) pathway. Moreover, fragmented damaged mitochondria
are secreted as DAMP. Vascular Endothelial Growth Factor (VEGF) is
upregulated under hypoxic conditions, notably by HIF-1-alpha.
HIF-1-alpha can accumulate in inflammatory cells through the Prolyl
Hydroxylase-pathway or TLR4-mTOR.
Increased glycolysis in monocytes sustains inflammatory cytokine production (IL-1β, TNF-α and IL-6), T cell impairment and pulmonary epithelial cell death (Metabolic reprogramming in COVID, International Journal of Molecular Sciences 2021, 22, 11475).
The
hyper-inflammatory stage of hypoxia is marked by activation of NF-kB,
NLRP3, mTOR and MAPK (mitogen-activated protein kinase), which induce
the cytokine cascade. The NAD+ (Nicotinamide Adenine Dinucleotide)
mitochondrial homeostatic regulators Sirtuins 3, 4 and 5 are
downregulated. Downregulated Sirtuins enhance ROS formation, which in
turn downregulates PHD, a regulator of HIF-1-alpha. HIF-1-alpha thus
stabilizes. Enzymes Glut1, LDH, PDHK, HK and COX-2 indicate the shift to
anabolic glycolysis (COVID sepsis: revisiting mitochondrial dysfunction
in pathogenesis, aging and inflammation, Inflammation Research, 3
August 2020). Glut2 uptake is stimulated by the EGFR.
In
addition, activation of complement C5a is involved in activating
pro-inflammatory neutrophils and macrophages by activation of PI3K/Akt
and MAPK pathways, stimulating endothelial damage and thrombosis. HIF-1a
in alveolar epithelial cells activates the NF-kB pathway, mediates cell
inflammation through CD4+ and CD8+ and enhances inflammatory cytokines
IL-2 and TNF-a, driving complement-activated endothelial damage
(COVID-driven endothelial damage: complement, HIF-1 and ABL2 are
potential pathways of damage and targets for cure, Annals of Hematology 9
June 2020).
Cells under oxygen deprivation induce adaptive
responses through AMP-kinase. When presented with high O2 tension,
Prolyl Hydroxylases (PHDs) oxidize HIF-1a under normoxic conditions.
Under low O2 tension, impaired succinate dehydrogenase leads to
accumulation of succinate with subsequent inhibition of PHDs.
Disproportional lactate production through glycolysis lowers cellular
pH. HIF-1 activates transcription of PDK1, encoding a kinase that
inactivates pyruvate dehydrogenase. Since pyruvate dehydrogenase is
essential for metabolizing acetyl-CoA in the mitochondrial matrix,
mitochondrial respiration is decreased (Hypoxia and mitochondrial
oxidative metabolism, Biochimica et Biophysica Acta 1797 (2010)).
2.2 The Warburg Effect in COVID via PI3K/AKT/mTOR and MAPK/ERK pathways induce microthrombosis
Pyruvate
Dehydrogenase (PDH) inhibition by Pyruvate kinase dehydrogenase 1
(PDK1) is stimulated by HIF-1a, PI3K/AKT/mTOR and the MAPK/ERK pathway,
activated by loss of P53. This means that the PI3K/AKT pathway, by
activating PDK1, blocks off pyruvate from feeding into mitochondria.
PDK1
and ERK in platelets stimulate aerobic glycolysis, which leads to
thromboxane activation and microthrombosis, while Platelet-derived
Growth Factor (PDGF) activates glycolysis via PI3K and HIF-1a. The
PI3K/AKT pathway activates ATP Citrate Lyase (ACLY), thereby enhancing
Acetyl-CoA to sustain Fatty Acid Synthesis (FAS). Acetyl-CoA Carboxylase
(ACC) sustains arachidonic acid synthesis, necessary for generation of
thromboxane.
AMP-activated protein kinase (AMPK) counteracts the Warburg effect and the PI3K/AKT/mTOR pathway. In addition, AMPK acts on production of the vasodilator Ang 1-7 in endothelial cells and stabilizes ACE2, decreasing vasoconstriction and platelet-derived microthrombosis (The Key role of the Warburg Effect in SARS-CoV-2 replication and associated inflammatory response, Biochimie 180 (2021)).
2.3 Inhibition of Bcl-2 family members leads to necrotic cell death
Bcl-2
family members tightly regulate Bax/Bak activation. Through Bax/Bak
activation, Bcl-2 family members regulate apoptosis by regulating
mitochondrial outer membrane permeability (BAX/BAK macropores regulate
the mtDNA extrusion). Upon permeabilization of the mitochondrial outer
membrane, cytochrome-C is released in order to activate Caspase, leading
to necrotic cell death. Right after SARS-CoV-2 infection, pro-apoptotic
genes are upregulated, among which the BCL2L11, leading to apoptosis by
inhibition of anti-apoptotic Bcl-2 and activation of Bax-Bak
(SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Exacerbates
Hypoxemia, Redox Biology 58 (2022)).
2.4. NSP4 and ORF9b of SARS-CoV-2 damage mitochondrial membrane potential (ΔΨ
m) and induce release of mtDNA into the cytosol
Mitochondrial
DNA (mtDNA) released into the cytosol enhances inflammation. mtDNA is
the result of mitochondrial damage following loss of mitochondrial
membrane potential. mtDNA are DAMPs, therefore promoting an inflammatory
cascade through the cGAS/STING1-mediated interferon signaling.
It
was found that transfection with SARS-CoV-2 proteins NSP2, NSP4, NSP6,
NSP8, ORF3a, ORF6 and ORF9b upregulate mitochondrial Reactive Oxygen
Species and downregulate mitochondrial membrane potential. Notably,
NSP4, ORF6 and ORF9b induce mtDNA release from epithelial cells.
MCL-1
regulates inner membrane vesicle formation and packaging of mtDNA.
Vesicles enclosing mtDNA are derived from the inner membrane and
extruded through BAX/BAK macropores. NSP4 acts on BAX/BAK to induce
macropore formation. ORF9b acts on MCL-1 to impair the inhibitory
(protective) effect on BAX/BAK macropore formation and to impair the
regulatory effect of MCL-1 on inner membrane stability and vesicle
formation (NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory
mitochondrial DNA release in inner membrane-derived vesicles, Cells 2022, 11).
Extracellular
mitochondrial DNA induces the release of pro-inflammatory cytokines
(PICs). The loss of mitochondrial (membrane) integrity and the release
of mtDNA induce a highly inflammatory IL1-β release. Moreover, loss of ΔΨ m and
mtDNA circulating in the cytosol contributes to chronic inflammation,
one of the appearances of Post-Acute SARS Syndrome/Long COVID.
2.5 Fibrosis and mitochondrial dysfunction
Excess
ROS generation under hypoxia, leads to damage of mitochondrial DNA,
proteins and lipids. The transition pore in the mitochondrial inner
membrane loses integrity, inducing mitochondrial depolarization and
swelling and loss of Electric Chain Transport (energy generation).
Increased mitochondrial permeability enhance the release of Cytochrome C into the cytosol.
Tissue
Growth Factor-beta (TGF-β), induced by anti-inflammatory macrophages,
stimulates fibroblasts through Smad signaling. Fibroblasts activate
fibro-collagen, Extracellular Matrix Molecules (ECM) and inhibit the
degradation of ECM molecules. The deletion of mitochondrial DNA, induced
by Angiotensin II, is reported in cardiac fibrosis. Mitochondrial
damage in alveolar epithelial cells contributes to pulmonary fibrosis.
Impaired mitophagy, the removal of dysfunctional and defective
mitochondria, contributes to fibrotic disease through activation of the
platelet PDGFR/PI3K/AKT pathway (Mitochondrial function in fibrotic
diseases, Cell Death Discovery (2020)6:80).
2.5.1 Alleviating pulmonary fibrosis through restoration of mitochondrial integrity and REDOX
Targeting mitochondrial Sirtuin-3 (SIRT3) could alleviate pulmonary fibrosis (Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target, Theranostics 2020;10(18)).
Furthermore, as hydrogen peroxide generation dependent on NOX4
contributes to fibroblast formation, LYCAT and NOX4-inhibition through
activation of the AMPK-pathway could attenuate lung fibrosis.
Metformin
attenuates lung fibrosis through activation of the AMPK-pathway, which
inhibits TGF-β induced NOX4 expression and ROS. Furthermore, AMPK
activation attenuates mTOR-activation (Metformin attenuates lung fibrosis development via NOX4 suppression, Respiratory Research 17, Art. 107(2016)).
Mitoquinone is an antioxidant that inhibits TGF-β and NOX4 expression;
mitoquinone also prevents Nrf2 downregulation (Mitoquinone ameliorates
pressure overload-induced cardiac
fibrosis and left ventricular dysfunction in mice, Redox Biology 21, 101100 (2019)).
2.5.2 Mitophagy impairment in spite of enhanced PINK1/Parkin
Infection
with SARS-CoV-2 causes mitochondrial lesion. In spite of PINK1/Parkin
activation and mitochondrial P62 accumulation, the normal process of
mitophagy of damaged mitochondria was inhibited. SARS-CoV-2 was found to
inhibit P62 and LC3 binding. The mitochondrial outer membrane protein
Tom20 was found to be used by SARS-CoV-2 to provide SARS-CoV-2 dsRNA
entry. Interestingly, Chaperonin HSP60 remained high following
SARS-CoV-2 infection, indicative of impaired clearance.
Knockdown
of Tom20 and application of Cyclosporin D inhibitor Cyclosporin A, each
decrease viral replication, indicating that loss of loss of
mitochondrial membrane integrity and MPTP opening are vital in
progression towards COVID (SARS-CoV-2 causes Mitochondrial Dysfunction and Mitophagy Impairment, Frontiers in Microbiology Vol. 12 (ahead of print)).
2.6 Mitochondrial damage leading to mismatched ventilation/perfusion (V/Q) in COVID
SARS-CoV-2
damages airway epithelial mitochondria (AEC) and pulmonary artery
smooth muscle cells (PASMC), thereby triggering apoptosis and impairing
hypoxic pulmonary vasoconstriction (HPV).
The M protein of
SARS-CoV-2 was found to depolarize the mitochondrial membrane potential
and increase the opening of the mitochondrial permeability transition
pore (mPTP). Nsp7, Nsp9 and the M protein induced apoptosis of airway
epithelial cells. While Ca2+ levels rise in response to hypoxia, M and
Nsp9 were found to inhibit the rise of Ca2+, reducing an accurate HPV
under hypoxic circumstances.
Increased Drp1-mediated fission and
Nsp7-induced inhibition of ETC electron transport chain Complex I
oxidative metabolism by SARS-CoV-2, contribute to mitochondrial
dysfunction in COVID. Through expression of Caspase7 and Annexin V,
apoptosis is induced. These factors contribute to impairment of
oxygen-sensing. As a result, impaired HPV leads to mismatched
ventilation/perfusion (V/Q) and leakage into the capillary (SARS-CoV-2 mitochondriopathy in COVID pneumonia exacerbates hypoxemia, Redox Biology 58 (2022) 102508).
3. Mitchondrial DNA and TLR-9 contribute to SARS-endothelial damage
SARS-CoV-2
was found to infect HUVECs, endothelial cells, through their expression
of ACE2 and TMPRSS2. The sera of COVID patients evidenced release of
mitochondrial cytochrome B and NAD dehydrogenase. Mitochondrial Complex I
protein levels were significantly decreased in COVID. Complex I is
necessary to maintain healthy ROS levels. A reduction of Complex I
levels induces mitochondrial damage. Abnormal levels of intracellular
Ca2+ concentrations indicate endothelial and mitochondrial dysfunction.
Reduction of Ca2+ disrupts vasodilation and induces endothelial damage.
From
SARS-CoV-1 (2003), it was known that the mitochondrial antiviral
signaling protein (MAVS) was disabled in order to manipulate
mitochondrial function.
The E-ORF and ORF10 of SARS-CoV-2 activates TLR-9 through multiple cells.
TLR-9
activates a hyperinflammatory state. Through an increase of mtDNA
release in HUVECs, TLR-9 becomes activated, which increases the
inflammatory pathways My88 and NF-kB, decreases eNOS and induces the
release of high levels of cytokine IL-6, thus creating a feedback loop
into endothelial damage and thrombosis (Mitochondrial DNA and TLR-9 activation contribute to SARS-CoV-2 induced endothelial cell damage, Vascular Pharmacology 142(2022)).
Reacties
Een reactie posten